Tg(IVL-MAP2K1*S217E*S221E)3062AFmw
Transgene Detail
|
|
| Symbol: |
Tg(IVL-MAP2K1*S217E*S221E)3062AFmw |
| Name: |
transgene insertion 3062A, Fiona M Watt |
| MGI ID: |
MGI:3690999 |
| Synonyms: |
InvEE mice, Tg(IVL-MEK1*S217E*S221E)3062Fmw |
| Transgene: |
Tg(IVL-MAP2K1*S217E*S221E)3062AFmw Location: unknown
|
| Alliance: |
Tg(IVL-MAP2K1*S217E*S221E)3062AFmw page
|
|
|
|
| Transgene Type: |
|
Transgenic (Constitutively active, Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A constitutively activated map 2 kinase kinase 1 having two point mutations causing Serine to glutamic acid residue changes at positions 217 and 221 was placed under the control of the involucrin promoter. Three founder lines are reported. Line 3062A has an intermediate relative insert copy number.
(J:92906)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:92906 Hobbs RM, et al., Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J Invest Dermatol. 2004 Sep;123(3):503-15 |
| All: |
4 reference(s) |
|